Product Image

Contributor Information

  • Name Lindy Durrant
  • Institute University of Nottingham

Tool Details

  • Tool name: Anti-C170 [NCRC22]
  • Clone: [NCRC22]
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; FACS
  • Strain: Balb/c
  • Description: Colorectal carcinoma is one of the most common malignant neoplasms. The cell line C170 was derived directly from a human primary tumor and as such was used as an immunogen to generate an antibody which is able to detect an epitope of a variety of colorectal cancerous cell lines.
  • Immunogen: C170 cells
  • Isotype: IgG1
  • Research area: Cancer; Cell biology; Tags and cell markers
  • Myeloma used: P3NSI-Ag-1

  • For Research Use Only

Target Details

  • Target: C170 - Colorectal carcinoma cell line
  • Target background: Colorectal carcinoma is one of the most common malignant neoplasms. The cell line C170 was derived directly from a human primary tumor and as such was used as an immunogen to generate an antibody which is able to detect an epitope of a variety of colorectal cancerous cell lines.

Application Details

  • Application: ELISA ; FACS

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

Related Tools

Product Image

Anti-CEACAM5/6/8 (CD66e/c/b) [4H6-20]

#153321
Product Image

Anti-TIGIT [13E7]

#153515
Product Image

Anti-CD81 [1s346]

#154244

References

  • •  Durrant et al. 1986. Br J Cancer. 53(1):37-45. PMID: 3947514.
  • •  Antigenicity of newly established colorectal carcinoma cell lines.